Astrazeneca Pens Fresh IBD Collab With Immunai Worth $85M
17 Oct 2025 //
FIERCE BIOTECH
AstraZeneca extends AI immuno-oncology R&D pact with Immunai
26 Sep 2024 //
FIERCE BIOTECH
Immunai and Baylor College of Medicine Provide Updated Interim Ph 1 Results
15 May 2023 //
BUSINESSWIRE
Koch leads mammoth $215M infusion into AI startup
27 Oct 2021 //
ENDPTS

Market Place
Sourcing Support